267 related articles for article (PubMed ID: 30078717)
1. Neurocognitive profiles in the prodrome to psychosis in NAPLS-1.
Velthorst E; Meyer EC; Giuliano AJ; Addington J; Cadenhead KS; Cannon TD; Cornblatt BA; McGlashan TH; Perkins DO; Tsuang MT; Walker EF; Woods SW; Bearden CE; Seidman LJ
Schizophr Res; 2019 Feb; 204():311-319. PubMed ID: 30078717
[TBL] [Abstract][Full Text] [Related]
2. Association of Neurocognition With Transition to Psychosis: Baseline Functioning in the Second Phase of the North American Prodrome Longitudinal Study.
Seidman LJ; Shapiro DI; Stone WS; Woodberry KA; Ronzio A; Cornblatt BA; Addington J; Bearden CE; Cadenhead KS; Cannon TD; Mathalon DH; McGlashan TH; Perkins DO; Tsuang MT; Walker EF; Woods SW
JAMA Psychiatry; 2016 Dec; 73(12):1239-1248. PubMed ID: 27806157
[TBL] [Abstract][Full Text] [Related]
3. Neuropsychology of the prodrome to psychosis in the NAPLS consortium: relationship to family history and conversion to psychosis.
Seidman LJ; Giuliano AJ; Meyer EC; Addington J; Cadenhead KS; Cannon TD; McGlashan TH; Perkins DO; Tsuang MT; Walker EF; Woods SW; Bearden CE; Christensen BK; Hawkins K; Heaton R; Keefe RS; Heinssen R; Cornblatt BA;
Arch Gen Psychiatry; 2010 Jun; 67(6):578-88. PubMed ID: 20530007
[TBL] [Abstract][Full Text] [Related]
4. Latent Profile Analysis and Conversion to Psychosis: Characterizing Subgroups to Enhance Risk Prediction.
Healey KM; Penn DL; Perkins D; Woods SW; Keefe RSE; Addington J
Schizophr Bull; 2018 Feb; 44(2):286-296. PubMed ID: 29036587
[TBL] [Abstract][Full Text] [Related]
5. The relationship of neurocognition and negative symptoms to social and role functioning over time in individuals at clinical high risk in the first phase of the North American Prodrome Longitudinal Study.
Meyer EC; Carrión RE; Cornblatt BA; Addington J; Cadenhead KS; Cannon TD; McGlashan TH; Perkins DO; Tsuang MT; Walker EF; Woods SW; Heinssen R; Seidman LJ;
Schizophr Bull; 2014 Nov; 40(6):1452-61. PubMed ID: 24550526
[TBL] [Abstract][Full Text] [Related]
6. The impact of inflammation on neurocognition and risk for psychosis: a critical review.
Kogan S; Ospina LH; Mittal VA; Kimhy D
Eur Arch Psychiatry Clin Neurosci; 2020 Oct; 270(7):793-802. PubMed ID: 31620871
[TBL] [Abstract][Full Text] [Related]
7. Latent class cluster analysis of symptom ratings identifies distinct subgroups within the clinical high risk for psychosis syndrome.
Ryan AT; Addington J; Bearden CE; Cadenhead KS; Cornblatt BA; Mathalon DH; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Woods SW; Cannon TD; Walker EF
Schizophr Res; 2018 Jul; 197():522-530. PubMed ID: 29279247
[TBL] [Abstract][Full Text] [Related]
8. Sexual dimorphisms and prediction of conversion in the NAPLS psychosis prodrome.
Walder DJ; Holtzman CW; Addington J; Cadenhead K; Tsuang M; Cornblatt B; Cannon TD; McGlashan TH; Woods SW; Perkins DO; Seidman LJ; Heinssen R; Walker EF
Schizophr Res; 2013 Mar; 144(1-3):43-50. PubMed ID: 23340377
[TBL] [Abstract][Full Text] [Related]
9. Cognitive dysfunction in a psychotropic medication-naïve, clinical high-risk sample from the ShangHai-At-Risk-for-Psychosis (SHARP) study: Associations with clinical outcomes.
Cui H; Giuliano AJ; Zhang T; Xu L; Wei Y; Tang Y; Qian Z; Stone LM; Li H; Whitfield-Gabrieli S; Niznikiewicz M; Keshavan MS; Shenton ME; Wang J; Stone WS
Schizophr Res; 2020 Dec; 226():138-146. PubMed ID: 32694037
[TBL] [Abstract][Full Text] [Related]
10. Metacognition strengthens the association between neurocognition and attenuated psychosis syndrome: Preliminary evidence from a pilot study among treatment-seeking versus healthy adolescents.
Koren D; Scheyer R; Stern Y; Adres M; Reznik N; Apter A; Seidman LJ
Schizophr Res; 2019 Aug; 210():207-214. PubMed ID: 30630704
[TBL] [Abstract][Full Text] [Related]
11. Stressor-Cortisol Concordance Among Individuals at Clinical High-Risk for Psychosis: Novel Findings from the NAPLS Cohort.
Cullen AE; Addington J; Bearden CE; Stone WS; Seidman LJ; Cadenhead KS; Cannon TD; Cornblatt BA; Mathalon DH; McGlashan TH; Perkins DO; Tsuang MT; Woods SW; Walker EF
Psychoneuroendocrinology; 2020 May; 115():104649. PubMed ID: 32197198
[TBL] [Abstract][Full Text] [Related]
12. From the psychosis prodrome to the first-episode of psychosis: No evidence of a cognitive decline.
Carrión RE; Walder DJ; Auther AM; McLaughlin D; Zyla HO; Adelsheim S; Calkins R; Carter CS; McFarland B; Melton R; Niendam T; Ragland JD; Sale TG; Taylor SF; McFarlane WR; Cornblatt BA
J Psychiatr Res; 2018 Jan; 96():231-238. PubMed ID: 29121595
[TBL] [Abstract][Full Text] [Related]
13. Clinical Profiles and Conversion Rates Among Young Individuals With Autism Spectrum Disorder Who Present to Clinical High Risk for Psychosis Services.
Foss-Feig JH; Velthorst E; Smith L; Reichenberg A; Addington J; Cadenhead KS; Cornblatt BA; Mathalon DH; McGlashan TH; Perkins DO; Seidman LJ; Stone WS; Keshavan M; Tsuang MT; Walker EF; Woods SW; Cannon TD; Bearden CE
J Am Acad Child Adolesc Psychiatry; 2019 Jun; 58(6):582-588. PubMed ID: 30797038
[TBL] [Abstract][Full Text] [Related]
14. Neurocognition in help-seeking individuals at risk for psychosis: Prediction of outcome after 24 months.
Metzler S; Dvorsky D; Wyss C; Nordt C; Walitza S; Heekeren K; Rössler W; Theodoridou A
Psychiatry Res; 2016 Dec; 246():188-194. PubMed ID: 27718468
[TBL] [Abstract][Full Text] [Related]
15. A longitudinal study of neurocognitive function in individuals at-risk for psychosis.
Keefe RS; Perkins DO; Gu H; Zipursky RB; Christensen BK; Lieberman JA
Schizophr Res; 2006 Dec; 88(1-3):26-35. PubMed ID: 16930949
[TBL] [Abstract][Full Text] [Related]
16. Use of Machine Learning to Determine Deviance in Neuroanatomical Maturity Associated With Future Psychosis in Youths at Clinically High Risk.
Chung Y; Addington J; Bearden CE; Cadenhead K; Cornblatt B; Mathalon DH; McGlashan T; Perkins D; Seidman LJ; Tsuang M; Walker E; Woods SW; McEwen S; van Erp TGM; Cannon TD;
JAMA Psychiatry; 2018 Sep; 75(9):960-968. PubMed ID: 29971330
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal change in neurocognition and its relation to symptomatic and functional changes over 2years in individuals at clinical high-risk for psychosis.
Shin YS; Kim SY; Lee TY; Hur JW; Shin NY; Kim SN; Shin MS; Kwon JS
Schizophr Res; 2016 Jul; 174(1-3):50-57. PubMed ID: 27068568
[TBL] [Abstract][Full Text] [Related]
18. Risk of violent behaviour in young people at clinical high risk for psychosis from the North American Prodrome Longitudinal Studies consortium.
Tronick LN; Mirzakhanian H; Addington J; Bearden CE; Cannon TD; Cornblatt BA; Keshavan M; Mathalon DH; McGlashan TH; Perkins DO; Stone W; Tsuang MT; Walker EF; Woods SW; Cadenhead KS
Early Interv Psychiatry; 2023 Aug; 17(8):759-770. PubMed ID: 36627192
[TBL] [Abstract][Full Text] [Related]
19. Characterising cognitive heterogeneity in individuals at clinical high-risk for psychosis: a cluster analysis with clinical and functional outcome prediction.
Haining K; Gajwani R; Gross J; Gumley AI; Ince RAA; Lawrie SM; Schultze-Lutter F; Schwannauer M; Uhlhaas PJ
Eur Arch Psychiatry Clin Neurosci; 2022 Apr; 272(3):437-448. PubMed ID: 34401957
[TBL] [Abstract][Full Text] [Related]
20. Baseline demographics, clinical features and predictors of conversion among 200 individuals in a longitudinal prospective psychosis-risk cohort.
Brucato G; Masucci MD; Arndt LY; Ben-David S; Colibazzi T; Corcoran CM; Crumbley AH; Crump FM; Gill KE; Kimhy D; Lister A; Schobel SA; Yang LH; Lieberman JA; Girgis RR
Psychol Med; 2017 Aug; 47(11):1923-1935. PubMed ID: 28249639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
